CryoCell International EBITDA vs. Return On Asset
| CCEL Stock | USD 9.09 0.09 1.00% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -12 M | Current Value -11.4 M | Quarterly Volatility 6.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.56 | 0.66 |
|
|
For CryoCell International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CryoCell International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CryoCell International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CryoCell International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CryoCell International over time as well as its relative position and ranking within its peers.
CryoCell |
CryoCell International's Revenue Breakdown by Earning Segment
Check out Trending Equities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Earnings Share (1.07) | Revenue Per Share 3.89 | Quarterly Revenue Growth 0.025 | Return On Assets (0) |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CryoCell International Return On Asset vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CryoCell International's current stock value. Our valuation model uses many indicators to compare CryoCell International value to that of its competitors to determine the firm's financial worth. CryoCell International is rated below average in ebitda category among its peers. It is rated below average in return on asset category among its peers . The company's current value of EBITDA is estimated at (11.38 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value CryoCell International by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CryoCell Return On Asset vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
CryoCell International |
| = | (10.42 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
CryoCell International |
| = | -0.0013 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CryoCell Return On Asset Comparison
CryoCell International is currently under evaluation in return on asset category among its peers.
CryoCell International Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CryoCell International, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CryoCell International will eventually generate negative long term returns. The profitability progress is the general direction of CryoCell International's change in net profit over the period of time. It can combine multiple indicators of CryoCell International, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 306.9 K | 322.2 K | |
| Operating Income | -14.1 M | -13.4 M | |
| Income Before Tax | -15.4 M | -14.6 M | |
| Total Other Income Expense Net | -954.4 K | -906.7 K | |
| Net Loss | -10.9 M | -10.4 M | |
| Income Tax Expense | -4.4 M | -4.2 M | |
| Net Income Applicable To Common Shares | 3.2 M | 2.1 M | |
| Net Loss | -8.6 M | -8.1 M | |
| Non Operating Income Net Other | -970.4 K | -921.9 K | |
| Net Interest Income | -1.1 M | -1.2 M | |
| Change To Netincome | -246.9 K | -234.6 K | |
| Net Loss | (1.03) | (0.98) | |
| Income Quality | (0.84) | (0.80) | |
| Net Income Per E B T | 0.82 | 1.32 |
CryoCell Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CryoCell International. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CryoCell International position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CryoCell International's important profitability drivers and their relationship over time.
Use CryoCell International in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CryoCell International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CryoCell International will appreciate offsetting losses from the drop in the long position's value.CryoCell International Pair Trading
CryoCell International Pair Trading Analysis
The ability to find closely correlated positions to CryoCell International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CryoCell International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CryoCell International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CryoCell International to buy it.
The correlation of CryoCell International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CryoCell International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CryoCell International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CryoCell International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CryoCell International position
In addition to having CryoCell International in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
To fully project CryoCell International's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CryoCell International at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CryoCell International's income statement, its balance sheet, and the statement of cash flows.